Browse #polb

When should you sell a stock?

Is a Bull Market on the way?

The Exchange

This company is outstanding, can you name another?

Taking Stock: What's been your biggest winner? What lessons did you learn from it?

Are UK Small Caps about to get a Boost?

Paul Hill: The impact of the gas price dropping, portfolio construction & stocks to follow

Is this company a good recovery play?

UK economic growth to rebound in late 2024

Inflation & Interest rates Higher for Longer = Markets Lower for Longer

Are we at Peak Fear?

A recession is looming but this is not a bad thing for the markets

Does your portfoli have exposure to AI?

Market Moving News

Poolbeg Pharma year in review: deepening strength

Taking Stock for 22/06/23 - Interest Rates, Mortgages, Winners & Losers plus Most Read

Jeremy Skillington of Poolbeg: This is a key step in the creation of a Phase I clinical trial ready oral vaccine candidate

Q&A: Poolbeg Pharma’s Jeremy Skillington on AI-led RSV breakthrough

Jeremy Skillington of Poolbeg Pharma talks about U.S. patents granted for POLB 001 & POLB 002

Jeremy Skillington of Poolbeg Pharma: Early data read out for POLB 001 indicates a successful LPS human challenge trial